This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
SALT LAKE CITY, June 25, 2013 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN), a company dedicated to helping people achieve healthy living through a combination of a compelling business opportunity and scientifically validated products, announced today that Dr. Joe McCord, LifeVantage's first Chief Science Officer, a member of the initial management team, past board member, LifeVantage Scientific Advisory Board member and pioneering researcher in anti-aging science has retired from the Company.
"Dr. McCord's co-discovery in 1969 of superoxide dismutase (SOD), an enzyme that eliminates free radicals, laid the foundation for a critical area of anti-aging research and provided the scientific foundation for LifeVantage's cornerstone products, Protandim®, the Nrf2 Synergizer® patented dietary supplement, TrueScience® Anti-Aging Cream and LifeVantage® Canine Health," said LifeVantage President and Chief Executive Officer Douglas C. Robinson.
"Since then," Robinson noted, "Dr. McCord has been named lead or co-author on a remarkable body of work, encompassing 212 published scientific articles on related matters, including the roles of SOD and/or Nrf2 in oxidative stress; heart, liver, lung, brain, muscle and other organ health; the mechanism and effects of Protandim; implications for cancer treatment, and more.
"In view of his long association with LifeVantage, dating from 2004, and his groundbreaking and continuing scientific exploration of oxidative stress, Nrf2 and Protandim, I know I am joined by the entire LifeVantage family, including more than 60,000 independent distributors worldwide and over 140,000 other customers, in celebrating Dr. McCord's service and wishing him the very best in the future," Robinson said.
Early LifeVantage investor and past board member H. Leigh Severance said of Dr. McCord, "Joe is one of those rare geniuses who not only discovers new scientific facts, but who encourages others to build on their groundbreaking research, expanding the breadth of knowledge and applications. Even more, Joe has the skills to help those of us in the financial community understand the value of his work, and to attract talented business executives capable of transforming science into extraordinarily successful commercial products. We are truly indebted to Joe for his great accomplishments."